Meta‐analysis evaluating apixaban in patients with atrial fibrillation and end‐stage renal disease r...
Meta‐analysis evaluating apixaban in patients with atrial fibrillation and end‐stage renal disease requiring dialysis
About this item
Full title
Author / Creator
Publisher
Japan: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Japan: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Background
Warfarin is considered the primary oral anticoagulant for patients with atrial fibrillation and end‐stage renal disease (ESRD) requiring dialysis. Although warfarin can offer significant stroke prevention in this population, the accompanying major bleeding risks make warfarin nearly prohibitive. Apixaban was shown to be superior to wa...
Alternative Titles
Full title
Meta‐analysis evaluating apixaban in patients with atrial fibrillation and end‐stage renal disease requiring dialysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_885d5c6be1e54e8b8b85e23190bf9420
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_885d5c6be1e54e8b8b85e23190bf9420
Other Identifiers
ISSN
1880-4276
E-ISSN
1883-2148
DOI
10.1002/joa3.13051
